During the first three months of semaglutide therapy, thyroid labs should typically be rechecked at 6-8 week intervals, then every 3 months once stable on a maintenance dose
For most patients, GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) require long-term use to maintain their benefits
In Texas, diabetes is an epidemic, with 12.4% of the adult population diagnosed with diabetes and an additional 34% with prediabetes, almost 10 million Texans in total
Research indicates that consuming collagen powder within 60 minutes post-exercise optimizes amino acid uptake for tissue repair
Retatrutide is showing extraordinary promise in clinical trials for severe obesity, but it is still an investigational medication undergoing Phase 3 evaluation because long-term safety, optimal dosing, side effects, and real-world outcomes still need rigorous study before FDA approval
[...] GLP-1 drugs offer non-surgical weight loss, while bariatric surgery provides lasting metabolic changeswe break down which option suits different needs